Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,200.07
(
-1.09%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 112325

Tuesday, 06/12/2012 5:45:53 PM

Tuesday, June 12, 2012 5:45:53 PM

Post# of 257580
The LLY/B-I diabetes JV issued several PR’s at ADA, which wrapped up today...

Phase-3 Tradjenta data:
http://finance.yahoo.com/news/boehringer-ingelheim-pharmaceuticals-inc-eli-140000500.html

Phase-2 data for LY2605541, a basal insulin compared to Lantus:
http://finance.yahoo.com/news/lilly-boehringer-ingelheim-present-data-203100108.html

Phase-2b extension data for Empagliflozin, a SGLT-2 inhibitor:
http://finance.yahoo.com/news/90-week-data-suggest-sustained-140000190.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today